Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest autoimmune diseases Stories

2013-09-23 10:22:14

Encouraging results from the T1DAL study (Targeting effector memory T cells with alefacept in new onset type 1 diabetes), led by Mark R. Rigby M.D., Ph.D. from Indiana University and Riley Hospital for Children in Indianapolis and sponsored by the Immune Tolerance Network (ITN) with additional support from JDRF, are published today in The Lancet Diabetes & Endocrinology. Alefacept, an engineered fusion protein targeting a surface molecule, CD2, found on T-lymphocytes, was the first...

2013-09-23 08:28:09

First and Only Anti-IL-12/23 Treatment Approved for Adult Patients Living with Psoriatic Arthritis HORSHAM, Pa., Sept. 23, 2013 /PRNewswire/ -- Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA(®) (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis. It is estimated that more than two million people in the U.S. are living with psoriatic...

2013-09-23 00:20:42

- Anti-IL-6R Nanobody, ALX-0061, to be developed in rheumatoid arthritis and systemic lupus erythematosus GHENT, Belgium and NORTH CHICAGO, Ill., Sept. 23, 2013 /PRNewswire/ -- Ablynx [Euronext Brussels: ABLX] and AbbVie [NYSE: ABBV] today announced that they have entered into a global license agreement to develop and commercialize the anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases. ALX-0061 is Ablynx's proprietary anti-IL-6R Nanobody that successfully completed...

2013-09-18 08:31:05

Be Joint Smart educates public about devastating disease affecting 300,000 Californians PORTLAND, Ore., Sept. 18, 2013 /PRNewswire-USNewswire/ -- For the second year, the National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic, inflammatory autoimmune disease that affects roughly 300,000 Californians and about 98,000 Greater Los Angeles residents. The two organizations will present the first psoriatic-arthritis...

2013-09-18 04:22:57

CANTERBURY, England, September 18, 2013 /PRNewswire/ -- Creabilis, a late clinical stage European dermatology company with a focus on pruritus (itch), today announces it has treated the first patients in its Phase 2b study of its lead product, CT327, in patients with atopic dermatitis (AD). The Phase 2b trial is a multi-centre, randomised, double-blind, placebo-controlled study in adult and adolescent patients (older than 12 years) with mild to moderate atopic...

2013-09-17 23:31:17

Karen Nicole Taylor transformed her life from sick and tired to happy and healthy with an organic anti-inflammatory diet. Now she's sharing her story and the details of her new diet with others on her new blog, http://www.HealingInflammationCafe.com, and in her upcoming new book, the "Inflammation Elimination Diet." Austin, Texas (PRWEB) September 17, 2013 Today Karen Nicole Taylor announced the launch of her new blog—http://www.HealingInflammationCafe.com. She created the...

2013-09-17 08:31:54

Be Joint Smart educates public about devastating disease affecting roughly 147,000 Floridians PORTLAND, Ore., Sept. 17, 2013 /PRNewswire-USNewswire/ -- For the second year, the National Psoriasis Foundation and the Arthritis Foundation will partner to educate Americans about psoriatic arthritis, a chronic, inflammatory autoimmune disease that affects roughly 147,000 Florida residents. The two organizations will present the first psoriatic-arthritis specific program--Be Joint Smart--in...

Gut Microbes Failure To Communicate Linked To Disease
2013-09-17 04:11:42

Brett Smith for redOrbit.com - Your Universe Online A new research review from Oregon State University has suggested that intestinal microbes play a big role as the immune system in keeping a person healthy. Review researchers said health issues such as autoimmune disease or clinical depression can sometimes be traced to immune dysfunction that starts with a “failure to communicate” in the human digestive tract. They theorized that future healthcare may be guided by the personalized...

2013-09-16 23:25:12

Speer Laboratories announces the long-awaited EMUAID® Therapeutic Moisture Bar. Pompano Beach, FL (PRWEB) September 16, 2013 New from EMUAID®, the maker of the industry-changing homeopathic First Aid Ointment, comes EMUAID® Therapeutic Moisture Bar. Cleansing is the most important part of skin care, and choosing the right soap is critical. Much more than a typical bar soap, this all natural, advanced formulation contains 5% Emu Oil along with Tea Tree Oil, Argan Oil,...

2013-09-14 23:01:57

New results from the National Health and Wellness Survey show few eligible patients are using biologic treatments. New York, NY (PRWEB) September 14, 2013 Despite the impairment caused by their disease, only 13 percent of rheumatoid arthritis patients in Brazil who are eligible for biologic therapy according to clinical guidelines are actually using a biologic, according to new findings from Kantar Health’s National Health and Wellness Survey (NHWS). The research will be presented today...